Zentalis Pharmaceuticals Promotes Co-Founder Cam Gallagher to President
marketwatch.com
news
2022-05-31 11:30:00

By Mary de Wet Zentalis Pharmaceuticals Inc. said Tuesday that it has promoted Cam Gallagher, a co-founder of the company, to president. Mr. Gallagher will report to Chief Executive Kimberly Blackwell, who was elevated to the role two weeks ago. In his new role, Mr. Gallagher will lead the corporate and business development initiatives, Dr. Blackwell said. One of Zentalis's major drug candidates is ZN-c3, a Wee1 inhibitor for advanced solid tumors. The biopharmaceutical company received a $25 million equity investment from Pfizer Inc.
